To include your compound in the COVID-19 Resource Center, submit it here.
ICOS Corp. (ICOS)
Ragen MacKenzie analyst Andrew Heyward upgraded ICOS from
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury